The global nuclear medicine market will reach $24 billion by 2030 (18 billion euros), with an annual average increase of 11%, according to a new market research report by MEDraysintell.
The growth will be driven by the therapeutic radiopharmaceutical market, which is expected to increase annually by 30% between 2013 and 2030. The diagnostic radiopharmaceutical market is expected to grow by 5% a year, mainly driven by volume increases, MEDraysintell said in its report.
In 2013, about 60% of the world market was based on technetium-99m; F-18 FDG accounts for about 20% of the market, MEDraysintell said. Therapeutic radiopharmaceuticals take up about 4% of the market but are expected to grow in the coming years, according to the report.
